Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | MYLK4 | Human | alpha-Zearalanol | multiple interactions | ISO | Mylk4 (Rattus norvegicus) | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of MYLK4 mRNA | CTD | PMID:35163327 | MYLK4 | Human | alpha-Zearalanol | decreases expression | ISO | Mylk4 (Rattus norvegicus) | 6480464 | Zeranol results in decreased expression of MYLK4 mRNA | CTD | PMID:35163327 | MYLK4 | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of MYLK4 3' UTR and Benzo(a)pyrene results in increased methylation of MYLK4 5' UTR | CTD | PMID:27901495 | MYLK4 | Human | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of MYLK4 mRNA | CTD | PMID:32234424 | MYLK4 | Human | benzo[e]pyrene | decreases methylation | EXP | | 6480464 | benzo(e)pyrene results in decreased methylation of MYLK4 intron | CTD | PMID:30157460 | MYLK4 | Human | bis(2-ethylhexyl) phthalate | increases expression | ISO | Mylk4 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in increased expression of MYLK4 mRNA | CTD | PMID:28085963 | MYLK4 | Human | bisphenol A | increases expression | ISO | Mylk4 (Mus musculus) | 6480464 | bisphenol A results in increased expression of MYLK4 mRNA | CTD | PMID:25594700 | MYLK4 | Human | bisphenol A | decreases expression | ISO | Mylk4 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of MYLK4 mRNA | CTD | PMID:32156529 | MYLK4 | Human | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of MYLK4 gene | CTD | PMID:31601247 | MYLK4 | Human | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of MYLK4 gene | CTD | PMID:31601247 | MYLK4 | Human | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of MYLK4 mRNA | CTD | PMID:29275510 | MYLK4 | Human | butanal | decreases expression | EXP | | 6480464 | butyraldehyde results in decreased expression of MYLK4 mRNA | CTD | PMID:26079696 | MYLK4 | Human | crocidolite asbestos | decreases methylation | EXP | | 6480464 | Asbestos and Crocidolite results in decreased methylation of MYLK4 5' UTR | CTD | PMID:29523930 | MYLK4 | Human | doxorubicin | decreases expression | ISO | Mylk4 (Mus musculus) | 6480464 | Doxorubicin results in decreased expression of MYLK4 mRNA | CTD | PMID:36227756 | MYLK4 | Human | fulvestrant | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of MYLK4 gene | CTD | PMID:31601247 | MYLK4 | Human | methapyrilene | decreases methylation | EXP | | 6480464 | Methapyrilene results in decreased methylation of MYLK4 intron | CTD | PMID:30157460 | MYLK4 | Human | O-methyleugenol | decreases expression | EXP | | 6480464 | methyleugenol results in decreased expression of MYLK4 mRNA | CTD | PMID:32234424 | MYLK4 | Human | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of MYLK4 mRNA | CTD | PMID:22230336 | MYLK4 | Human | pentanal | decreases expression | EXP | | 6480464 | pentanal results in decreased expression of MYLK4 mRNA | CTD | PMID:26079696 | MYLK4 | Human | perfluorooctanoic acid | multiple interactions | ISO | Mylk4 (Rattus norvegicus) | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of MYLK4 mRNA | CTD | PMID:35163327 | MYLK4 | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of MYLK4 mRNA | CTD | PMID:37042841 | MYLK4 | Human | triptonide | increases expression | ISO | Mylk4 (Mus musculus) | 6480464 | triptonide results in increased expression of MYLK4 mRNA | CTD | PMID:33045310 | |